Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Rankning i aktier #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Aktiekurs
$29.06
Senast synkroniserad: 2023-02-23
Marknadsvärde
$682.73M
Förändring (1 dag)
-0.48%
Förändring (1 år)
0.00%
Land
US
Handel CinCor Pharma, Inc. (CINC)

Kategori

Aktiekurshistorik för CinCor Pharma, Inc. (CINC)
Högsta slutkurs: $29.26 den 2023-02-01

Lägsta slutkurs: $16.50 den 2022-01-01
Aktiekurshistorik för CinCor Pharma, Inc. från 2022 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 146.11%
2022 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH